rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Neil Cashman

Chief Scientific Officer

Company insider

Files Form 4 as: Chief Scientific Officer, ProMIS Neurosciences.

Every Form 4 they filed

In numbers

Trades disclosed
12
Buys
1
Sells
0
Bought
$15K
Sold
$0
Companies
1
Companies where not an officer
0
First trade
23 Aug 2023
Last trade
20 May 2026
Last filed
22 May 2026

Companies traded

Where they are an officer
PMN ProMIS NeurosciencesDirector, Officer · Biotechnology · last 20 May 20261 buy · 0 sells

Activity over time

1 Feb 2025 – 1 Oct 2026
01Feb 25Jul 25Dec 25May 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
20 May 2026filed 22 May 2026PMN ProMIS Neurosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—50,000 at $0.00filing
20 May 2026filed 22 May 2026PMN ProMIS Neurosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—50,000 at $0.00filing
3 Feb 2026filed 5 Feb 2026PMN ProMIS NeurosciencesBiotechnologySEC FORM 4 Code A$50K4,122 at $12.13filing
3 Feb 2026filed 5 Feb 2026PMN ProMIS Neurosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—4,122filing
3 Feb 2026filed 5 Feb 2026PMN ProMIS Neurosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—4,122filing
3 Feb 2026filed 5 Feb 2026PMN ProMIS NeurosciencesBiotechnologySEC FORM 4 Code A$50K4,122 at $12.13filing
22 Sep 2025filed 24 Sep 2025PMN ProMIS Neurosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—165,000 at $0.00filing
10 Feb 2025filed 12 Feb 2025PMN ProMIS NeurosciencesBiotechnologySEC FORM 4 Bought$15K15,000 at $0.97filing
18 Nov 2024filed 20 Nov 2024PMN ProMIS Neurosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—200,000 at $0.00filing
26 Oct 2023filed 30 Oct 2023PMN ProMIS Neurosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—12,500 at $0.00filing
23 Aug 2023filed 25 Aug 2023PMN ProMIS Neurosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—10,643filing
23 Aug 2023filed 25 Aug 2023PMN ProMIS NeurosciencesBiotechnologySEC FORM 4 Code A—10,643filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care1

Buys in green, sells in red, by the company’s sector.

Related people

Ivana RubinoChief Commercial Officer · Chief Commercial Officer at ProMIS Neurosciences, filing Form 4 there in the last year
Johanne KaplanChief Development Officer · Chief Development Officer at ProMIS Neurosciences, filing Form 4 there in the last year
Max A. MilburyPrincipal Accounting Officer · Principal Accounting Officer at ProMIS Neurosciences, filing Form 4 there in the last year
Josh Mandel-BrehmChief Executive Officer · Director at ProMIS Neurosciences, filing Form 4 there in the last year
William W. WymanDirector · Director at ProMIS Neurosciences, filing Form 4 there in the last year